IBS Diagnostics with

Dr. Mark Pimentel

What Is ibs-smart™ And How Does It Diagnose IBS?

 

 How Food Poisoning Leads to IBS

 

Biomarker and Blood Test Validation

 

Clinical Applications of

ibs-smart™ for Gastroenterologists

 

Clinical Applications of ibs-smart for Primary Care Physicians

 
 

Selecting Patients and Patient Counseling

 

 Understanding the Test Results

 

Recommendations for Patients With Positive Test Results

IBS and SIBO

 

Mark Pimentel, MD, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles, California.

 

Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS and the relationship between gut flora composition and human disease. 

 

 

A few of Dr. Pimentel’s most significant accomplishments include:

 

  1. Discovered rifaximin as a treatment for irritable bowel syndrome (IBS). 

  2. Developed the first blood test for IBS on the basis of IBS being derived from acute gastroenteritis. 

  3. Described the association between IBS and bacterial overgrowth which forms the basis for microbiome therapies in this condition. 

  4. Uncovered the methanogen (Methanobrevibacter smithii) as an agent for causing constipation in humans. 

  5. Discovered the use of lovastatin as a microbiome treatment for constipation on the basis of inhibiting methane production by methanogens.

 

ibs-smart™️ is the only licensed, patented antibody blood test for the diagnosis of IBS. See the full list of patents here

  • Facebook
  • Twitter
  • Instagram

ibs-smart™️ is brought to patients by Gemelli Biotech. 

Learn more about our work, principles and leadership at www.gemellibiotech.com.

  • LinkedIn - Black Circle
  • Facebook
  • Twitter